Squadron Capital Management LLC Hedge Fund

Location: WESTMONT, IL

CIK: 0002050709 · Show all filings

Period: Q1 2026 (← Previous)

Filing Date: May 15, 2026

Total Value: $273M (100.0% shares, 0.0% debt)

Holdings (37)

New Positions (19)

NKTR NEKTAR THERAPEUTICS 3.3%
Value $8.994M Shares 125,000 Est. Cost Unrealized
ANL ADLAI NORTYE LTD 3.2%
Value $8.755M Shares 1,265,231 Est. Cost Unrealized
ZNTL ZENTALIS PHARMACEUTICALS INC 3.1%
Value $8.497M Shares 3,631,000 Est. Cost Unrealized
SCYX SCYNEXIS INC 2.6%
Value $6.976M Shares 7,608,695 Est. Cost Unrealized
RLAY RELAY THERAPEUTICS INC 2.5%
Value $6.691M Shares 672,500 Est. Cost Unrealized
KALV KALVISTA PHARMACEUTICALS INC 2.3%
Value $6.341M Shares 315,000 Est. Cost Unrealized
CCCC C4 THERAPEUTICS INC 2.2%
Value $5.918M Shares 2,250,000 Est. Cost Unrealized
KPTI KARYOPHARM THERAPEUTICS INC 1.5%
Value $4.178M Shares 750,000 Est. Cost Unrealized
PMN PROMIS NEUROSCIENCES INC 1.5%
Value $4.127M Shares 324,977 Est. Cost Unrealized
IDYA IDEAYA BIOSCIENCES INC 1.5%
Value $3.998M Shares 120,000 Est. Cost Unrealized
IDYA IDEAYA BIOSCIENCES INC 1.3%
Value $3.475M Shares 104,300 Est. Cost Unrealized
ALXO ALX ONCOLOGY HLDGS INC 1.1%
Value $2.927M Shares 1,460,000 Est. Cost Unrealized
CNTX CONTEXT THERAPEUTICS INC 1.1%
Value $2.882M Shares 1,100,000 Est. Cost Unrealized
SLGL SOL-GEL TECHNOLOGIES LTD 0.9%
Value $2.456M Shares 31,000 Est. Cost Unrealized
RLAY RELAY THERAPEUTICS INC 0.5%
Value $1.492M Shares 150,000 Est. Cost Unrealized
ZNTL ZENTALIS PHARMACEUTICALS INC 0.3%
Value $936K Shares 400,000 Est. Cost Unrealized
TXMD THERAPEUTICSMD INC 0.3%
Value $849K Shares 420,421 Est. Cost Unrealized
HOWL WEREWOLF THERAPEUTICS INC 0.2%
Value $469K Shares 563,535 Est. Cost Unrealized
NEUP NEUPHORIA THERAPEUTICS INC 0.1%
Value $312K Shares 76,728 Est. Cost Unrealized

Exited Positions (15)

Decreased Positions (8)